Patrick Schöffski, MD, MPH, on RCC: Final Results of the EORTC 90101 CREATE Trial

2018 Genitourinary Cancers Symposium

Patrick Schöffski, MD, MPH, of Catholic University Leuven, discusses findings on the effect of crizotinib on disease control in patients with advanced papillary renal cell carcinoma type 1 with MET mutations or amplification (Abstract 580).

Aug

Today In Oncology

Drug Combination Design for Multiple Myeloma Using an AI Platform

FDA Grants Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis

Definitive Pelvic Radiation Therapy Plus Chemotherapy and Survival in Newly Diagnosed Metastatic Cervical Cancer

Impact of Peer-Review Intervention on Radiotherapy Schedules for Palliative Treatment of Bone Metastases

FDA Grants Breakthrough Device Designation for Cancer Detection Liquid Biopsy

;